Cannabis Law Report

AUGUST 10, 2021

As psychedelic therapy trials approach FDA approval, researchers express the urgent need to ensure effectiveness and accessibility to communities of color. Drugs: Education, Prevention and Policy , 28 (3), 211–214. Madison Natarajan, MS. – August 5, 2021. Thrul, J., & Garcia-Romeu, A. link] (Link). Source: [link].

Clinical Trials 105

Clinical Trials Research and Development Therapy Treatment 105

Cannabis Law Report

JUNE 19, 2022

The Center for Psychedelic Drug Research and Education (CPDRE) was approved by the Ohio State College of Social Work faculty in January, and its director, Assistant Professor of Social Work Alan Davis , officially took the helm in March. Initial goals of the center are focused on research and educational initiatives. Jason Slot.

Education 52

Education Research and Development Therapy Clinical Trials 52

Cannabis Law Report

JULY 7, 2021

Tilray is embarking on a push to educate more German doctors about the benefits of prescribing medical cannabis, as the weed giant seeks to cement its dominance in the highly-profitable European medical market. The Canadian weed giant marked a milestone in Germany this week, harvesting the country’s first medical cannabis crop.

Clinical Trials 81

Clinical Trials Education Data Pharmaceutical 81

CannaMD

JUNE 2, 2021

” They cited the need for more and better patient education on the potential use of marijuana for the treatment of Parkinson’s disease, as well as the need for treating physicians to become better informed on the subject, and the need for more clinical trials.

Patients 105

Patients Clinical Trials Treatment Research and Development 105

Veriheal

JUNE 30, 2023

For their analysis, researchers conducted qualitative interviews with 13 individuals who had participated in a psilocybin clinical trial. The 13 individuals were chosen because of their reported improvements in negative drinking behavior following the clinical trial.

Clinical Trials 98

Clinical Trials Research and Development Therapy Policy 98

NewsMunchies

NOVEMBER 12, 2021

In clinical trials, psilocybin (the psychoactive substance in mushrooms) has shown tremendous promise in treating severe depression, post-traumatic stress disorder, and other mental illnesses. Additional clinical trials underway in the U.S. Allowing people to be educated sets them up for a safe, enjoyable “trip.”.

Clinical Trials 90

Clinical Trials Therapy Decriminalization DEA 90

Veriheal

MAY 26, 2022

In turn, cannabis advocates have struggled to properly educate the public with the limited amount of scientific evidence available. states pass relevant legislation and educating doctors about the power of cannabis medicine. But one area of cannabis medicine is still lagging behind—research.

Advocacy 98

Advocacy Patients Clinical Trials Education 98

Cannabis Law Report

DECEMBER 20, 2021

(“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing product candidates for pain management, CNS disorders and anti-viral indications, signed a clinical trial agreement with Altasciences Company, Inc.,

Clinical Trials 40

Clinical Trials Chronic Pain Pharmaceutical Data 40

Cannabis Life Network

MAY 27, 2021

Early scientific research and clinical trials have shown promise in their ability to help supplement treatments for people with various neurological disorders with cannabidiol (CBD). CBD is a naturally occurring chemical compound found in cannabis, such as hemp.

Clinical Trials 76

Clinical Trials CBD Treatment Hemp 76

FloridaMarijuana.net

AUGUST 15, 2018

A January 2018 Scientific American article titled “As Vets Demand Cannabis for PTSD, Science Races to Unlock Its Secrets” details a 2009 clinical trial in Canada which showed that the nighttime administration of THC reduced the frequency and intensity of nightmares in 72 percent of the 47 patients studied.”.

Treatment 182

Treatment Marijuana Research and Development Therapy 182

Puff Puff Post

SEPTEMBER 16, 2019

This new initiative developed by Santé Cannabis equips physicians with the most up-to-date clinical guidelines, support networks, online and in-person training opportunities so they can prescribe and monitor cannabinoid treatment plans with confidence. 71,000+ interactions with healthcare professionals. ABOUT SPECTRUM THERAPEUTICS.

Programs 108

Programs Research and Development Education Treatment 108

Veriheal

MARCH 2, 2024

The revised legislation would permit clinical use and production of cannabis for medical CBD products, like Epidiolex , that have been approved in the U.S. and Europe to treat severe epilepsy, as well as other medical conditions. The post Is Weed Legal in Japan? Cannabis Legalization Bill Explained appeared first on Cannabis Central.

Legalization 110

Legalization Epilepsy Clinical Trials THC 110

The Cannigma

AUGUST 31, 2021

Medical societies are slowly providing more CME (continuing medical education) to doctors on cannabis, however, that educational content tends to be slanted toward risk mitigation. Fortunately, there is a slowly growing community of cannabis physicians who are learning through trial and error and from one another.

Education 103

Education Clinical Trials Medicine Policy 103

FloridaMarijuana.net

AUGUST 15, 2018

Additionally, the ACPA reported on a clinical trial that suggests that inhaled cannabis may provide short-term relief from Neuropathy. These damaged nerve fibers send incorrect signals to other pain centers. The impact of a nerve fiber injury includes a change in nerve function both at the site of injury and areas around the injury.”

Chronic Pain 150

Chronic Pain Marijuana Patients Clinical Trials 150

TheAnswerPage

JANUARY 11, 2022

As the Editor-in-Chief of the medical education website called TheAnswerPage.com for nearly two decades, I have assessed multiple educational gaps in the healthcare community. Thus, an educational gap developed, creating a less than ideal situation for medical marijuana patients. So, why did this educational gap develop?

Patients 98

Patients Education Marijuana Therapy 98

Peninsula Alternative Health

MAY 15, 2019

The huge difference between medical cannabis and traditional pharmaceuticals is that cannabis is quickly becoming accessible to treat conditions before clinical trials and standard dosing protocols have been established. This cannot be said for most if any prescribed or over the counter medicines on today's market. References Staff, T.

Conditions 89

Conditions Therapy Cannabinoids Epilepsy 89

Cannabis Law Report

JULY 27, 2021

plan to conduct a controlled clinical trial to further understand the effects of CBD in epilepsy treatment. Through research and education, Realm of Caring (RoC) is facilitating the mainstream acceptance of cannabinoid-based therapies and building an empowered community. About Realm of Caring.

Data 81

Data Epilepsy Research and Development Clinical Trials 81

Cannabis Law Report

JUNE 29, 2021

Synergetic Press and the Multidisciplinary Association for Psychedelic Science (MAPS) are pleased to announce they have entered into a copublishing relationship effective May 1, 2021 which will greatly expand the availability of education about psychedelics and psychedelic therapy. founder and executive director of MAPS.

Therapy 69

Therapy Research and Development Clinical Trials Education 69

The Cannigma

DECEMBER 14, 2021

The development of analytical standards, regulations, more data from toxicology studies and clinical trials, as well as substantial consumer education will all be imperative to the development of the hydrogenated cannabinoid market. The post What is HHC and how does it affect the body? appeared first on The Cannigma.

Research and Development 116

Research and Development Clinical Trials Cannabinoids THC 116

Cannabis Law Report

JULY 28, 2021

We believe in diversity and inclusion of people of all backgrounds, genders, races, ethnicities, sexual orientations, educational backgrounds, military and veteran status,?religions, 2-3 years of relevant experience in clinical trials, research methods, or statistical design and analysis. religions, abilities, and perspectives.

Clinical Trials 81

Clinical Trials Research and Development Data Environment 81

Cannabis Law Report

AUGUST 21, 2019

In November 2018, the legal status of cannabis was changed to allow specialist clinicians to legally prescribe cannabis-derived medicinal products to patients with an exceptional clinical need, following a high-profile media campaign. Doctors don’t have any education, training, and they don’t understand, she said.

Clinical Trials 81

Clinical Trials Nerve Pain Medicine Epilepsy 81

Project CBD

FEBRUARY 28, 2023

The following excerpt analyzes CBD marketing trends reported by the American Botanical Council, a membership organization that educates consumers, health care professionals, journalists, and others about the safe and effective use of medicinal plants. (E-commerce sales of CBD in the U.S. in 2021 reached $2 billion, according to Statistica.)

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

JUNE 4, 2021

Clinical trial information: NCT03276572 ( [link] ). Abstract Number: 5015. Date and Time: Available Starting June 4, 2021 , 9:00 am (EST). The Abstract from this study has been released on the ASCO Annual Meeting website ( [link] ). The full ASCO meeting program is available at: www.asco.org. About AIkido Pharma Inc.

Data 100

Data Research and Development Clinical Trials Therapy 100

Cannabis Law Report

JANUARY 7, 2020

PsychedeliTech is our newest “Incubaby” designed to create a global ecosystem to accelerate psychedelic innovation by investing in research, education and clinical trials. Let me introduce you to our newest venture Psychedelitech Inc. and invite you to invest with us in this exciting opportunity.

Events 59

Events Clinical Trials Decriminalization Education 59

Veriheal

JANUARY 28, 2022

Poleg noted that “clinical trials testing cannabis treatments for autism usually involve strains containing very large amounts of CBD–due to this substance’s anti-inflammatory properties, and because it does not produce a sense of euphoria.”.

Oil 104

Oil THC Research and Development Treatment 104

Veriheal

MAY 12, 2021

In light of such, and the fact that cancer is a common qualifying condition for cannabis, this research team took to expanding the available basic information on cannabis in the cancer population in order to provide clinical trial designers with better information needed for planned studies.

Patients 98

Patients Consumption Clinical Trials Education 98

FloridaMarijuana.net

OCTOBER 9, 2018

In 2017, The National Academies of Sciences, Engineering, and Medicine published a statement that the use of cannabis for the treatment of pain is supported by “well-controlled clinical trials and that there is substantial evidence that cannabis is an effective treatment for chronic pain in adults.”.

Terpenes 100

Terpenes Chronic Pain Strains Clinical Trials 100

Cannabis Law Report

APRIL 21, 2022

The availability of larger quantities of cGMP-compliant MDMA will facilitate ongoing clinical trials and provide for future therapeutic use following anticipated regulatory approvals. in each of the four validation trials with an acceptable yield, which is a noteworthy accomplishment.

Clinical Trials 52

Clinical Trials Research and Development Therapy Media 52

CannaTech

SEPTEMBER 16, 2018

The Need for Cannabis Education Tailored to Patient and Doctor. Healthcare professionals will always be the best people to consider what role cannabis will play in a patient’s health and wellness; doctors are in a dire need of education and guidance to help them offer this medicine to patients.

Education 66

Education Medicine Clinical Trials Patients 66

Cannabis Law Report

NOVEMBER 19, 2021

It has been designated a Breakthrough Therapy by the FDA and the results of our pivotal Phase 3 clinical trial were published in Nature Medicine or profiled on the front page of The New York Times. MAPS PBC is a Public Benefit Corporation, with a dual mandate to generate shareholder value and public benefit. Key Responsibilities.

Clinical Trials 52

Clinical Trials Research and Development Therapy Compliance 52

Miss Marijuana

JUNE 30, 2019

As the industry leader, we are committed to advancing research and education to help more and more consumers realize the many benefits of hemp CBD supplementation.”. If you find yourself being a Nelly, try listening to Douglas MacKay’s, Senior Vice President of Scientific and Regulatory Affairs of CV Sciences, optimism: .

Sleep 72

Sleep CBD Clinical Trials Oil 72

Cannabis Law Report

AUGUST 3, 2021

For CUNY, the Contract operationalizes the CDC’s ‘ Guidance for Institutions of Higher Education ’ aimed at disease control and minimizing the risk of exposure in education settings. FDA) or equivalent foreign regulatory agencies to conduct clinical trials and whether and when, if at all, they will receive final approval from the U.S.

Clinical Trials 81

Clinical Trials Therapy Collective Research and Development 81

Cannabis Law Report

JANUARY 26, 2022

The Innovation Passport does not reduce the burden of demonstrating that a treatment may be safe and effective, but does provide research organizers with expert advice, patient input, and collaboration throughout the clinical trial design and development process through a product-specific Target Development Profile.

Therapy 52

Therapy Clinical Trials Research and Development Treatment 52

Cannabis Law Report

JANUARY 27, 2022

Based on cohorts of children with special educational needs, the prevalence of fragile X syndrome (FXS) is estimated to be 1 in 4,000 in males, and 1 in 8,000 in females. The majority of industry-sponsored drugs in active clinical development for FXS are in Phase II, with two drugs in Phase III. CLINICAL TRIAL LANDSCAPE.

Clinical Trials 40

Clinical Trials Therapy Cannabinoids Topical 40

Cannabis Law Report

DECEMBER 9, 2021

(the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPD) a clinical stage pharmaceutical development company is pleased to announce that it has completed the manufacturing of its clinical grade supply (“cGMP”) of AP-188 (“ N , N -Dimethyltryptamine or DMT”) at Canadian manufacturer Dalton Pharma Services.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

Cannabis Law Report

OCTOBER 2, 2021

The results of our successful pivotal Phase 3 clinical trial were recently published in Nature Medicine and profiled on the front page of The New York Times. The right candidate will have a passion for clinical research in novel therapeutics and a proven track record of regulatory affairs experience. Key Responsibilities.

Clinical Trials 52

Clinical Trials Research and Development Compliance Compliance 52

CannaTech

JANUARY 27, 2019

From clinical trials to cosmetics, the region is gearing up for high return and low cost of production. From hiring local employees to educating the public and navigating national regulations, relationships with the locals are key. land, labs, licenses). That’s not the only high, low combo to note.

Clinical Trials 81

Clinical Trials Cultivation Research and Development Pharmaceutical 81